Information was provided by a consumer regarding an implantable intrathecal pump intended to deliver fentanyl [500.0 mcg/ml] at 181.33 mcg/day and bupivacaine [25.0 mg/ml] at 9.066 mg/day, indicated for non-malignant pain.It was reported that the patient felt the pump has moved or has tilted.The event date was unknown, per the patient ¿about a week ago¿ from the report date ((b)(6) 2018).It was stated that she could always feel the notches at the top of the pump, which is always at a tilt, but has never been able to feel the whole pump.It was stated that it feels like the bottom has settled and is more in the stomach, and the top is sticking out.The patient reported that on (b)(6) 2018, she experienced migraines that go across the cheeks and eyes and her eyes are swollen and ¿vluty,¿ and the pain is going up into her head, and coming down into the back of the neck and top of the shoulders.It was also reported that the patient feels she is not getting her personal therapy manager (ptm) over the pump in the right area.The patient reported that on (b)(6) 2018, she was not feeling the bolus.It was stated that she normally feels a warmth as the bolus delivers, and she had not felt the warmth from the last two boluses.It was noted that the patient considered the change in therapy/symptoms gradual.It was stated that the patient had not had any falls or traumas.The patient was redirected to follow-up with her managing physician.No further complications were reported.
|